Heart association offers advice on who should get genetic testing

By Theresa Pablos, LabPulse.com contributing writer

July 24, 2020 -- The American Heart Association has released a new scientific statement on genetic testing and counseling for inherited cardiovascular diseases, including guidance on which patients stand to benefit the most.

Published on July 13 in Circulation: Genomic and Precision Medicine, the statement provides information on what the scientific community does and doesn't know about genes and genetic combinations that may influence heritable heart disease risk.

It also suggests best practices for genetic testing in patients with heart disease.The society advised that genetic testing should typically be limited to patients with confirmed or suspected diagnosis of a cardiovascular condition that may have an inherited component, such as cardiomyopathies, thoracic aortic aneurysms and dissection, arrhythmic disorders, and familial hypercholesterolemia. Patients with a high risk of inherited cardiac conditions, including those with a first-degree relative who has tested positive for a specific mutation, should also consider genetic testing.

The American Heart Association also recommended patients interested in genetic testing to first undergo genetic counseling to learn about the process and potential risks related to testing. Genetic counseling is also recommended after testing to help patients understand their results and potential consequences.

"With most genetic cardiovascular diseases, inheriting a mutation (or variant) from a parent substantially increases the risk of getting the disease but does not guarantee the disease," stated Dr. Kiran Musunuru, PhD, chair of the writing group for the scientific statement and professor of cardiovascular medicine and genetics at the Perelman School of Medicine at the University of Pennsylvania, in a press statement.

"In some cases, it might be possible to act early and prevent the disease," Musunuru said. "In other cases, having the mutation for a genetically caused cardiovascular condition might lead to different and possibly more aggressive treatment."

Who stands to gain from polygenic risk scoring for heart disease?
Polygenic risk scoring may benefit some middle-aged people at borderline risk for cardiovascular events and has potential as a one-time test for those...
Genetic risk scoring not ready for prime time in heart disease
Polygenic scores did not show a meaningful benefit for risk stratification in heart disease in two studies published in the February 18 issue of the Journal...
Testing for inherited cholesterol condition falls far short
Though much is known about the nature and risks of familial hypercholesterolemia, testing and diagnosis rates still fall far short, according to a global...
Cardiovascular genetic risk score guides PCSK9 therapy
Results from a genetic risk test were significantly associated with risk for cardiovascular events in a new analysis of the large outcomes study of the...

Copyright © 2020 LabPulse.com

Last Updated eh 7/28/2020 12:37:57 AM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email